What 7 Analyst Ratings Have To Say About Merck & Co
Portfolio Pulse from Benzinga Insights
Over the last quarter, Merck & Co (NYSE:MRK) has received various analyst ratings, with 2 bullish, 2 somewhat bullish, and 3 indifferent. The company's average 12-month price target is $122.29, an increase of 8.22% over the past month. The ratings are based on the company's predicted future earnings and the predictability of its revenue streams.
August 22, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Merck & Co has received mixed analyst ratings over the last quarter, with an average 12-month price target of $122.29. This could influence investor sentiment and the company's stock price.
Analyst ratings can significantly influence investor sentiment and the stock price. While the ratings for Merck & Co are mixed, the increased price target could lead to positive sentiment among investors, potentially impacting the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100